Narayana Hrudayalaya Moves Forward with NH Integrated Care Demerger

Narayana Hrudayalaya Limited held important meetings with its shareholders and creditors on April 2, 2026, to secure approval for the planned demerger of NH Integrated Care Private Limited. The company is expected to submit the results of these NCLT-directed meetings to stock exchanges by April 4, 2026, a significant step in its corporate restructuring.

Key Meeting Details

The company held virtual meetings on April 2, 2026, for its shareholders and creditors (both secured and unsecured). The main purpose was to consider and approve a plan, known as a Scheme of Arrangement, to demerge NH Integrated Care Private Limited (Demerged Company) from Narayana Hrudayalaya Limited (Resulting Company). Remote e-voting on these proposals occurred from March 30 to April 1, 2026.

Why This Matters

This move is part of a broader strategy to streamline operations. By separating clinical services under NH Integrated Care, Narayana Hrudayalaya aims to create more focused business entities. The demerger is expected to allow Narayana Hrudayalaya to concentrate on its core hospital operations, while NH Integrated Care can focus on its specific segment, potentially improving efficiency and shareholder value.

The Backstory

Narayana Hrudayalaya Limited, recognized for its extensive network of hospitals and healthcare facilities, has been undergoing strategic restructuring. The company's Board approved a comprehensive demerger scheme on December 12, 2025. This scheme involves transferring clinical services operations, primarily comprising 10 clinics in Bengaluru, from its wholly-owned subsidiary, NH Integrated Care Private Limited (NHIC), back to the parent entity. However, the Narayana Aarogyam preventive healthcare platform will remain with NHIC, allowing it to focus on specialized preventive care services. These recent meetings are a necessary step to obtain required regulatory and NCLT approvals for this approved scheme.

Expected Changes

Following shareholder and creditor approval, Narayana Hrudayalaya Limited would absorb the clinical services business. NH Integrated Care Private Limited is expected to continue as a subsidiary, likely focusing on its preventive healthcare platform. As NHIC is a wholly-owned subsidiary, no new share issuance or change in the overall shareholding pattern is anticipated from this specific demerger.

Key Risks and Approvals

A primary challenge is securing final approvals from regulatory bodies and the National Company Law Tribunal (NCLT). Delays in these approvals could postpone the completion of the demerger. The company must ensure full compliance with all SEBI and NCLT regulations throughout this process.

Peer Comparison

Narayana Hrudayalaya operates in a competitive healthcare landscape alongside major players such as Apollo Hospitals Enterprise Ltd., Fortis Healthcare Ltd., Max Healthcare Institute Ltd., and Global Health Ltd. These entities also focus on expanding their hospital networks and service offerings, though specific demerger activities among peers are not directly comparable to this event.

Financial Context

For the year ended March 31, 2025, the clinical services undertaking subject to demerger reported a turnover of ₹39.94 crore. This represented approximately 1.11% of Narayana Hrudayalaya's total standalone turnover for the same period.

Next Steps for Investors

Investors will watch for the immediate submission of meeting results to stock exchanges by April 4, 2026. Subsequent approvals from the NCLT and other relevant authorities will be crucial. The market will monitor further announcements regarding the demerger timeline and its potential impact on the operational focus and financial performance of both Narayana Hrudayalaya Ltd. and NH Integrated Care.